Zydus Lifesciences Ltd.

Zydus Lifesciences’ wholly owned subsidiary -- Zydus Pharmaceuticals USA Inc., USA, (ZPUI) has incorporated a wholly owned subsidiary in the name of a Zylidac Bio LLC (Zylidac) in the United States of America on July 11, 2025, and is yet to commence its business operation. The immediate objective of incorporation of Zylidac is to acquire the target assets of Agenus.

Earlier, ZPUI has entered into a definitive agreement with Zylidac, and Agenus Inc., USA (collectively referred to as ‘Agenus’), to acquire, directly or through its affiliates, two U.S. based biologics manufacturing facilities of Agenus, one in Emeryville, CA and another in Berkeley, CA (‘the target assets’). 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.